cbdMD (YCBD) Other Non-Current Assets (2016 - 2025)
cbdMD (YCBD) reported Other Non-Current Assets of $62708.0 for Q4 2025, down 98.79% on a YoY basis from $5.2 million in Q4 2024, and little changed sequentially from $62708.0 in Q3 2025.
cbdMD (YCBD) Other Non-Current Assets (2016 - 2025) Analysis & Trends
cbdMD (YCBD) has 10 years of Other Non-Current Assets data on file, last reported at $62708.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Non-Current Assets fell 98.79% year-over-year to $62708.0; the trailing twelve-month figure through Dec 2025 stood at $62708.0 (down 98.79% YoY), and the FY2025 full-year result was $62708.0, down 98.5% from the prior year.
- Other Non-Current Assets steadied at $62708.0 in Q4 2025, from $62708.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $88.4 million in Q3 2021 to a low of $62708.0 in Q1 2025.
- A 5-year average of $9.1 million and a median of $191657.0 in 2022 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets tumbled 99.8% in 2022 and jumped 4625.25% in 2024, its largest moves.
- Tracing YCBD's Other Non-Current Assets over 5 years: stood at $69.6 million in 2021, then plunged by 99.8% to $138708.0 in 2022, then slipped by 4.69% to $132203.0 in 2023, then jumped by 3819.94% to $5.2 million in 2024, then slumped by 98.79% to $62708.0 in 2025.
- Business Quant data shows YCBD's Other Non-Current Assets at $62708.0 in Q4 2025, $62708.0 in Q3 2025, and $4.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn | 62,708.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 62,708.00 |
| Sep 30, 2025 | 62,708.00 |
| Jun 30, 2025 | 4.30 Mn |
| Mar 31, 2025 | 62,708.00 |
| Dec 31, 2024 | 5.18 Mn |
| Sep 30, 2024 | 4.19 Mn |
| Jun 30, 2024 | 6.55 Mn |
| Mar 31, 2024 | 132,203.00 |
| Dec 31, 2023 | 132,203.00 |
| Sep 30, 2023 | 138,708.00 |
| Jun 30, 2023 | 138,708.00 |
| Mar 31, 2023 | 138,708.00 |
| Dec 31, 2022 | 138,708.00 |
| Sep 30, 2022 | 244,606.00 |
| Jun 30, 2022 | 244,606.00 |
| Mar 31, 2022 | 138,708.00 |
| Dec 31, 2021 | 69.65 Mn |
| Sep 30, 2021 | 88.38 Mn |
| Jun 30, 2021 | 529,583.00 |
| Mar 31, 2021 | 789,583.00 |